Get started
Author

Eva Fonseca Aizpuru

Observed names: E Fonseca Aizpuru, E. Fonseca Aizpuru, E.M. Fonseca Aizpuru, E.M. Fonseca-Aizpuru, EM Fonseca-Aizpuru, Eva Fonseca-Aizpuru, Eva María Fonseca Aizpuru, Eva Mª Fonseca Aizpuru, Eva-María Fonseca-Aizpuru
ORCID: 0000-0003-0578-7474
Observed ORCID: 0000-0003-0578-7474
OpenAlex ID: A5081962720
WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales
2022 · Manuel Rubio-Rivas, José María Mora-Luján, et al. · Journal of General Internal Medicine · 85
In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
2021 · Inés Suárez-García, Isabel Perales-Fraile, et al. · PLoS ONE · 58
PDF
The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals
2020 · María Mateos González, Elena Sierra Gonzalo, et al. · Journal of Clinical Medicine · 42
PDF
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
2022 · Gabriela Hernández-Molina, Belchin Kostov, et al. · Rheumatology · 34
PDF
Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial
2023 · Patricia Fanlo, Borja del Carmelo Gracia-Tello, et al. · JAMA Network Open · 28
PDF
Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study
2021 · Claudia Josa-Laorden, Anxela Crestelo-Vieitez, et al. · Journal of Clinical Medicine · 21
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial
2022 · Alberto Cecconi, Pablo Martinez-Vives, et al. · Scientific Reports · 11
PDF
Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort
2024 · Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, et al. · Viruses · 6
PDF
Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry
2022 · Jose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, et al. · Journal of Clinical Medicine · 4
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19
2022 · Cristina Lavilla Olleros, Cristina Ausín García, et al. · PLoS ONE · 3
Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial
2024 · Lucía Llanos Jiménez, Beatriz Alvarez-Alvarez, et al. · Journal of Clinical Medicine · 2
PDF
Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 Registry
2023 · Manuel Méndez Bailón, Noel Lorenzo Villalba, et al. · Journal of Clinical Medicine · 2
PDF
1941 - Utilidad Del Tratamiento Con Mepolizumab En La Granulomatosis Eosinofílica Con Poliangeítis
2023 · Roser Solans Laqué, Ana Noblejas Mozo, et al. · Revista Clínica Española · 1
Circulación colateral tras trombosis de la vena cava superior y hemorragia digestiva secundaria
2018 · S.M. Santos-Seoane, E.M. Fonseca-Aizpuru, et al. · Revista Clínica Española · 1
Elderly-Onset Sarcoidosis and the Influence of Age on Clinical Phenotypes: A Multicentre Analysis from the SARCOGEAS Registry
2026 · María García-González, Carlos Feijoo-Massó, et al. · Journal of Clinical Medicine
Three clinical and immunological phenotypes of systemic lupus erythematosus onset identified through clustering analysis: data from the RELES registry
2026 · Andrés González-García, Martin Fabregate, et al. · Arthritis Research & Therapy
Biological therapy in Takayasu arteritis. Results from the REVAS registry
2026 · J Mestre-Torres, JL Callejas-Rubio, et al. · European Journal of Internal Medicine
Reacciones adversas a pembrolizumab en pacientes con cáncer
2026 · Sara Rodríguez Arboleya, Alba Vegas Tapia, et al. · Medicina Clínica
Adverse reactions to pembrolizumab in patients with cancer
2026 · Sara Rodríguez Arboleya, Alba Vegas Tapia, et al. · Medicina Clínica (English Edition)
1879 - Anticuerpos Antisintetasa: ¿qué Nos Encontramos?
2025 · Alejandro Licetti Bermúdez, Paula Martínez García, et al. · Revista Clínica Española
429 - Descripción De Los Pacientes Con Anticuerpos Anti-ku Positivos En Nuestro Centro En Cuatro Años
2024 · Sara Rodríguez Arboleya, Eva Fonseca Aizpuru, et al. · Revista Clínica Española
453 - Descripción De Los Pacientes Con Anticuerpos Anti-nor90 Positivos En Nuestro Centro En Cuatro Años
2024 · Sara Rodríguez Arboleya, Eva Fonseca Aizpuru, et al. · Revista Clínica Española
1783 - ¿qué Hacemos Con Cn-1a Positivo?: Revisión De 9 Casos
2024 · Alejandro Licetti Bermúdez, Eva Fonseca Aizpuru, et al. · Revista Clínica Española
44 - Terapia Biológica Y Enfermedad De Takayasu: Análisis Descriptivo Del Uso Y Efectividad Del Registro Español De Vasculitis (revas)
2024 · Jaume Mestre Torres, Cristina Nolla Fontana, et al. · Revista Clínica Española
Cardiac amyloidosis worsens prognosis in patients with heart failure: findings from the PREVAMIC study
2024 · R. Ruiz Hueso, P. Salamanca Bautista, et al. · Revista Clínica Española (English Edition)
Works count: 34
Citation count: 298
H-index: 7
I10-index: 7
Year
Topic
Type